세계 백신 기술 시장

Highlights:

The global market for vaccine technologies is expected to grow from $45.0 billion in 2023 to $65.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.8% from 2023 to 2028.

The global market for subunit, recombinant, polysaccharide, and conjugate vaccines is expected to grow from $23.5 billion in 2023 to $34.4 billion by 2028, at a CAGR of 7.9% from 2023 to 2028.

The global market for live-attenuated vaccines is expected to grow from $8.4 billion in 2023 to $12.1 billion by 2028, at a CAGR of 7.6% from 2023 to 2028.

Report Scope:

This report explains critical trends in the vaccine industry. It discusses the market determinants, which act as motivating or restraining factors and provides insights to stakeholders and potential entrants.

This report includes only human vaccines; animal vaccines have not been considered in this report.

This study looks at research and development (R&D) spending, increasing competition and new technologies, which are giving direction to the market. These advancements, new product launches and changing lifestyles are influencing future market growth.

Company mergers, acquisition strategies and collaborations are also covered in this report. Additionally, this study discusses the strengths and weaknesses of each strategy type, considering new technologies, growing competition and changing customer needs.

The market has been analyzed based on the application of current vaccines. Categories considered in this report include pneumococcal vaccines; diphtheria, tetanus vaccines; HPV vaccines; MMR vaccines; and other vaccines including rotavirus vaccines, influenza vaccines, hepatitis B vaccines, chickenpox vaccines, polio vaccines, BCG, and yellow fever vaccines.

This study details market growth among vaccine manufacturers and end users. Genomic research centers, academic institutions, government and private laboratories, various hospital settings, and pharmaceutical, diagnostic and biotechnology companies and physicians will find this study to be of interest.

This report provides useful information to all market players, potential entrants, government agencies and other interested parties. As the report covers geographic regions in detail, companies interested in expanding geographic reach will also find this study useful.

Report Includes:

• 34 data tables and 63 additional tables
• An up-to-date overview of the global markets for vaccine technologies
• Analyses of the global market trends, with historical market revenue data (sales figures) from 2020 to 2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028
• Estimate of the market size and revenue forecast for the global market, and a corresponding market share analysis based on technology, disease indication, age group and region
• Facts and figures pertaining to the market drivers, opportunities and challenges, emerging technologies, global R&D spending, and the regulatory landscape
• Assessment of present and future strategies in the innovation-driven vaccine technologies market, and a look at the vaccines for humans and their immunization schedule
• Discussion of the importance of ESG in the market for vaccine technologies, including consumer attitudes, the impact of ESG factors on company performance, and ESG practices of leading companies
• Review of patents and patent applications
• Overview of the major vendors, along with an analysis of the industry structure, including company market shares, recent M&A activity, and venture funding
• Analysis of the competitive landscape based on recent developments and segmental revenues
• Profiles of the leading companies

Table of Contents

Chapter 1 Introduction

• Study Background
• Study Goals and Objectives
• Reasons for Doing this Study
• Scope of Report
• What's New in This Update?
• Methodology
• Information Sources
• Geographic Breakdown
• Segmentation Breakdown

Chapter 2 Summary and Highlights

• Market Outlook
• Market Insights

Chapter 3 Market and Technology Background

• Definitions
• Immune System and Vaccines
• Components of the Immune System
• Cells of the Immune System
• Immune Response
• Major Histocompatibility Complex (MHC)
• Immunization and Vaccines
• Disorders of the Immune System
• Impact of Lifestyle on the Immune System
• How Vaccines Work
• Principles of Immunization
• Types of Immunity
• Advantages of Vaccination
• History of Vaccines
• Vaccines and Immunization, Overview
• Types of Vaccines
• Attenuated (Live) Vaccines
• Inactivated (Killed) Vaccines
• Toxoid Vaccines
• Subunit Vaccines
• Conjugate Vaccines
• Recombinant Vector Vaccines
• DNA Vaccines
• RNA Vaccines
• Immunization
• Advantages of Immunization
• Adjuvants and Excipients
• Pathogen Components
• Particulate Adjuvants
• Infectious Diseases Preventable by Vaccine
• Human Diseases
• Viral Diseases
• Bacterial Diseases
• Regulatory Aspects
• World Health Organization (WHO) Prequalified Vaccines
• New Product Approvals
• Recalls
• Significant Regulatory Developments in Vaccines

Chapter 4 Market Dynamics

• Overview
• Market Drivers
• Growing Awareness of Immunization
• Growing Investments and R&D
• New Vaccines
• Prevalence of Infectious Diseases
• Market Restraints
• Vaccine Development and Pricing
• Market Opportunities
• Increased Demand from Emerging Markets
• Therapeutic Vaccines

Chapter 5 Global Market for COVID-19 Vaccines

• Overview
• COVID-19 Vaccine Technologies
• Advent of mRNA Technology
• Impact of COVID-19 on Routine Infant Vaccination
• COVID-19 Disruptions
• Stagnating Global Coverage Rate
• Progress and Challenges by Country and Region

Chapter 6 Market Breakdown by Technology

• Global Market for Vaccine Technologies by Technology
• Subunit, Recombinant, Polysaccharide, and Conjugate Vaccines
• Live-Attenuated Vaccines
• Inactivated Vaccines
• Toxoid Vaccines
• Other/Combination Vaccines

Chapter 7 Market Breakdown by Disease

• Global Market for Vaccine Technologies by Disease
• Pneumococcal
• Diphtheria and Tetanus
• HPV
• MMR
• Others

Chapter 8 Market Breakdown by Age Group

• Global Market for Vaccine Technologies by Age Group Treated
• Pediatrics
• Adolescents and Adults

Chapter 9 Market Breakdown by Region

• Global Market for Vaccine Technologies by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World

Chapter 10 Emerging Technologies and Developments

• Developments
• mRNA Vaccines
• Viral Vector Vaccines
• Nanoparticle Vaccines
• DNA Vaccines
• Virus-Like Particle (VLP) Vaccines
• Self-Amplifying RNA Vaccines
• Innovative Adjuvants
• AI and Computational Biology
• Personalized Vaccines
• Plant-Based Vaccines

Chapter 11 Competitive Landscape

• Competitive Landscape
• Company Share Analysis

Chapter 12 Company Profiles

• ABBOTT
• ASTRAZENECA
• BAVARIAN NORDIC
• BHARAT BIOTECH INTERNATIONAL LTD.
• EMERGENT BIOSOLUTIONS INC.
• GSK PLC.
• JOHNSON & JOHNSON SERVICES INC.
• MERCK & CO. INC.
• MITSUBISHI TANABE PHARMA CORP.
• PANACEA BIOTEC LTD.
• PFIZER INC.
• SANOFI

Chapter 13 Appendix: List of Acronyms

• Acronyms